Name
Industry Expert Session IVA (Non-Accredited): Lunch
Date & Time
Thursday, September 4, 2025, 12:05 PM - 1:05 PM
Description
A Portfolio of Immunotherapies Leading the Way in Multiple Myeloma Treatment: TECVAYLI Overview & DARZALEX FASPRO PERSEUS TRIAL
John Renshaw, MD | Texas Oncology-San Antonio Medical Center | San Antonio, Texas, USA
This activity is sponsored by Johnson & Johnson
Location Name
GRB LEVEL 3, ROOM 310